rheumatic fever: Rheumatic fever (RF) is a multisystem inflammatory disease occurring as a post-infectious, nonsuppurative sequela of untreated streptococcus pyogenes (Group A streptococcus [GAS]) pharyngitis, and mainly occurs in individuals aged 5 to 15 years. The most common presenting signs are fever, migratory polyarthritis and carditis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1280 |
6. Filter based on genotype QC (FinnGen only) |
1280 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Rheumatic fever incl heart disease
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 20505 | 10490 | 9486 |
| Only index persons | 9214 | 4842 | 4372 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.30 | 0.27 |
| Only index persons | 0.17 | 0.18 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 61.81 | 65.18 | 57.95 |
| Only index persons | 51.22 | 55.20 | 46.81 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1280 | 586 | 694 |
| Unadjusted period prevalence (%) | 0.26 | 0.20 | 0.31 |
| Median age at first event (years) | 51.77 | 47.21 | 55.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1169
- Matched controls
- 11689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I06.9
ICD-10 Finland
Rheumatic aortic valve disease, unspecified
+∞
205.4
191
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
22.4
135.2
201
107
B01AA03
ATC
warfarin; systemic
4.2
105.4
567
2160
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.2
88.5
265
527
C01AA05
ATC
digoxin; systemic
4.4
78.2
333
966
I35.0
ICD-10 Finland
Aortic (valve) stenosis
5.7
76.4
242
508
5273
FHL
Repair with flap prosthesis or graft
120.9
73.9
79
7
I05.0
ICD-10 Finland
Mitral stenosis
+∞
73.7
70
*
I06.0
ICD-10 Finland
Rheumatic aortic stenosis
+∞
70.5
67
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.6
66.8
366
1301
I01.0
ICD-10 Finland
Acute rheumatic pericarditis
+∞
64.1
61
*
I08.0
ICD-10 Finland
Disorders of both mitral and aortic valves
+∞
62.0
59
*
3950A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic stenosis
+∞
62.0
59
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
8.9
61.7
138
174
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
6.5
60.9
169
295
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
12.0
53.4
100
90
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.7
51.5
490
2456
C03CA01
ATC
furosemide; systemic
2.6
50.8
598
3381
39501
ICD-8 Finland
Diseases of aortic valve, Cum insufficientia (febris rheumatica inactiva)
+∞
49.3
47
*
I05.1
ICD-10 Finland
Rheumatic mitral insufficiency
+∞
48.3
46
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.9
48.1
361
1548
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
49.8
47.4
57
12
I05.2
ICD-10 Finland
Mitral stenosis with insufficiency
+∞
47.2
45
*
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
6.3
46.9
131
228
I06.1
ICD-10 Finland
Rheumatic aortic insufficiency
+∞
46.1
44
*
3951A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic insufficiency
+∞
46.1
44
*
3952A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic stenosis with insufficiency
+∞
45.1
43
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
13.4
44.6
79
63
I50.0
ICD-10 Finland
Congestive heart failure
3.6
44.4
229
746
5253
FHL
Cardiac lung machine
13.7
43.4
76
59
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.0
41.2
140
307
4241B
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]
53.1
38.8
46
9
39097
ICD-8 Finland
Rheumatic fever without mention of heart involvement, Suspecta
+∞
37.7
36
*
I06.2
ICD-10 Finland
Rheumatic aortic stenosis with insufficiency
+∞
36.6
35
*
39500
ICD-8 Finland
Diseases of aortic valve, Cum stenosi (febris rheumatica inactiva)
+∞
36.6
35
*
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
5.8
36.0
106
196
I05.9
ICD-10 Finland
Mitral valve disease, unspecified
+∞
35.6
34
*
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
21.7
35.5
52
25
C03DA01
ATC
spironolactone; oral
3.0
34.1
224
855
81
HP
Angiography of the heart and coronary arteries
3.5
32.8
170
547
XF640
NOMESCO Finland
NA
5.7
31.9
95
178
I34.1
ICD-10 Finland
Mitral (valve) prolapse
7.1
31.2
78
116
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.4
31.0
335
1696
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
5.4
30.8
97
194
K83
ICPC
Heart valve disease NOS
11.7
30.6
57
51
39502
ICD-8 Finland
Diseases of aortic valve, Cum stenosi et insufficientia (febris rheumatica inactiva)
+∞
30.3
29
*
C07AA07
ATC
sotalol; systemic
4.0
30.2
128
347
4241A
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]
60.0
30.2
35
6
39401
ICD-8 Finland
Diseases of mitral valve, Cum insufficientia (febris rheumatica inactiva)
+∞
28.2
27
*
207
Kela drug reimbursment
Chronic arrhythmias
2.4
27.2
267
1276
3941A
ICD-9 Finland
Diseases of mitral valve, Rheumatic mitral insufficiency
+∞
26.1
25
*
62
HP
Catheterization and pressure measurement of the right side of the heart
23.2
25.3
36
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
25.2
293
1514
39099
ICD-8 Finland
Rheumatic fever without mention of heart involvement, Unspecified
+∞
25.1
24
*
I50.1
ICD-10 Finland
Left ventricular failure
3.3
24.8
134
442
C07AB07
ATC
bisoprolol; oral
1.9
24.5
632
4473
AN1
HP
Coronary angiography
2.5
24.1
206
909
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
55.2
23.1
27
5
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.5
22.8
111
338
21
HP
Aortic Valve Replacement (AVR)
27.9
22.3
30
11
3940A
ICD-9 Finland
Diseases of mitral valve, Mitral stenosis
+∞
21.9
21
*
4241C
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA/STENOSIS VALVULAE AORTAE (NON RHEUM)]
63.8
21.9
25
*
C07AB02
ATC
metoprolol; systemic
2.0
21.8
350
2055
39199
ICD-8 Finland
Rheumatic fever with heart involvement, Other active rheumatic heart disease
+∞
20.9
20
*
39197
ICD-8 Finland
Rheumatic fever with heart involvement, Suspecta
+∞
20.9
20
*
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
21.9
20.9
30
14
TFP20
NOMESCO Finland
Cardiodefibrillation
2.9
20.8
133
491
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
8.7
20.5
44
52
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.0
20.4
126
455
61
HP
Catheterization and pressure measurement of the left side of the heart
5.4
20.1
61
118
I07.1
ICD-10 Finland
Tricuspid insufficiency
+∞
19.8
19
*
39400
ICD-8 Finland
Diseases of mitral valve, Cum stenosi (febris rheumatica inactiva)
+∞
19.8
19
*
I00
ICD-10 Finland
Rheumatic fever without mention of heart involvement
74.8
19.7
22
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
19.7
512
3533
4240A
ICD-9 Finland
Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]
40.8
19.5
24
6
J01DA01
ATC
[U] cefalexin; systemic
1.8
19.5
717
5519
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
12.0
19.3
35
30
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
5.7
19.1
55
100
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
17.9
18.3
28
16
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
5.1
18.0
57
116
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
17.9
211
1077
3960A
ICD-9 Finland
Diseases of mitral and aortic valves, Mitral valve stenosis and aortic valve stenosis
+∞
17.7
17
*
5284
FHL
Mitral defect correction with flap prosthesis or graft
96.5
17.6
19
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.8
17.6
122
474
B01AB05
ATC
enoxaparin; parenteral
1.8
17.3
358
2268
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
17.0
357
2272
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
6.4
16.8
44
71
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
16.7
245
1369
3942A
ICD-9 Finland
Diseases of mitral valve, Mitral stenosis with insufficiency
+∞
16.7
16
*
R06.0
ICD-10 Finland
Dyspnoea
1.8
16.2
315
1948
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
3.2
15.9
85
278
I34.8
ICD-10 Finland
Other nonrheumatic mitral valve disorders
33.9
15.8
20
6
39409
ICD-8 Finland
Diseases of mitral valve, Unspecified
+∞
15.7
15
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
15.5
314
1960
R50.9
ICD-10 Finland
Fever, unspecified
2.1
15.4
182
925
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
15.2
92
327
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
6.4
14.9
39
63
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
14.9
332
2136
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.3
14.8
142
655
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.9
14.6
91
331
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
5.7
14.4
41
74
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
9.3
14.2
29
32
M04AA01
ATC
allopurinol; systemic
2.0
14.0
207
1153
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
5.1
13.8
43
87
39509
ICD-8 Finland
Diseases of aortic valve, Unspecified
+∞
13.6
13
*
39403
ICD-8 Finland
Diseases of mitral valve, Operata (febris rheumatica inactiva)
+∞
13.6
13
*
AC2
HP
MVR bio
34.4
13.5
17
5
C01DA14
ATC
isosorbide mononitrate; oral
1.8
13.5
282
1768
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
21.4
13.3
19
9
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
40.5
13.2
16
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
13.1
360
2449
K78
ICPC
Atrial fibrillation/flutter
2.3
13.0
129
606
I33.9
ICD-10 Finland
Acute endocarditis, unspecified
22.8
12.9
18
8
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
12.7
363
2496
I07.2
ICD-10 Finland
Tricuspid stenosis with insufficiency
+∞
12.5
12
*
39402
ICD-8 Finland
Diseases of mitral valve, Cum stenosi et insufficientia (febris rheumatica inactiva)
+∞
12.5
12
*
39503
ICD-8 Finland
Diseases of aortic valve, Operata (febris rheumatica inactiva)
+∞
12.5
12
*
A12BA01
ATC
potassium chloride; oral
2.4
12.5
107
466
J01FF01
ATC
clindamycin; systemic
1.7
12.5
290
1875
AP2
HP
Catheterization of the right side of the heart
13.3
12.4
21
16
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
3.8
12.3
52
142
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
12.3
124
586
AB2
HP
AVR bio, stent
6.5
12.2
31
49
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.9
12.2
76
278
C02EA02
ATC
NA
2.5
12.0
96
406
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
11.9
209
1231
25
HP
Valve and coronary artery bypass surgery
30.3
11.7
15
5
XF404
NOMESCO Finland
Ambulatory ECG
2.2
11.6
122
590
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.7
11.5
302
2018
I01.9
ICD-10 Finland
Acute rheumatic heart disease, unspecified
+∞
11.5
11
*
I08.1
ICD-10 Finland
Disorders of both mitral and tricuspid valves
+∞
11.5
11
*
I08.3
ICD-10 Finland
Combined disorders of mitral, aortic and tricuspid valves
+∞
11.5
11
*
C01BD01
ATC
amiodarone; systemic
3.3
11.5
56
173
XFE00
NOMESCO Finland
Epicardial ultrasonography
3.6
11.4
50
142
WX872
NOMESCO Finland
Intensive care
2.8
11.3
71
260
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.9
11.3
36
75
22
HP
Mitral valve Replacement (MVR)
35.4
11.3
14
*
K84
ICPC
Heart disease other
3.7
11.3
48
133
J01CA04
ATC
amoxicillin; systemic
1.6
11.2
810
6905
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.3
10.7
53
166
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
10.1
10.5
20
20
I01.1
ICD-10 Finland
Acute rheumatic endocarditis
+∞
10.4
10
*
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
8.3
10.3
22
27
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
23.6
10.2
14
6
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
10.2
334
2350
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
10.2
53
172
C08DA01
ATC
verapamil; systemic
2.6
10.2
76
310
H02AB06
ATC
prednisolone; systemic
1.5
10.0
496
3840
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
9.9
148
823
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
8.2
9.8
21
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
9.8
76
316
J01FA06
ATC
roxithromycin; oral
1.5
9.7
414
3098
C09AA02
ATC
enalapril; systemic
1.6
9.6
267
1799
L04AA01
ATC
[U] ciclosporin; systemic
5.1
9.6
29
58
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
9.5
125
662
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
9.5
85
381
39604
ICD-8 Finland
Diseases of mitral and aortic valves, Non operata
+∞
9.4
9
*
24
HP
Multi-valve repair or other valve surgery
+∞
9.4
9
*
74679
ICD-8 Finland
Congenital anomalies of heart, Aliae malformationes valvulae aortae sive ventriculi sinistri
+∞
9.4
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
9.3
182
1108
J01FA10
ATC
azithromycin; systemic
1.5
9.3
499
3915
R04.0
ICD-10 Finland
Epistaxis
2.1
9.2
100
489
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
5.0
9.1
28
57
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
9.1
48
159
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
9.0
45
143
I50
ICD-10 Finland
Heart failure
2.6
9.0
65
261
4289X
ICD-9 Finland
Heart failure, unspecified
4.6
8.8
29
64
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.7
154
905
42410
ICD-8 Finland
Chronic disease of endocardium, Aortae, non operata
50.3
8.7
10
*
74673
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae aortae
50.3
8.7
10
*
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
8.5
668
7708
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
8.5
112
592
J01MA12
ATC
levofloxacin; systemic
1.6
8.4
218
1435
L54.0*I00
ICD-10 Finland
Erythema marginatum in acute rheumatic fever
+∞
8.3
8
*
I01.8
ICD-10 Finland
Other acute rheumatic heart disease
+∞
8.3
8
*
3910A
ICD-9 Finland
Rheumatic fever with heart involvement, Acute rheumatic pericarditis
+∞
8.3
8
*
42411
ICD-8 Finland
Chronic disease of endocardium, Aortae, operata
+∞
8.3
8
*
39601
ICD-8 Finland
Diseases of mitral and aortic valves, Mitralium operata
+∞
8.3
8
*
4140B
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]
4.4
8.2
28
65
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
9.0
8.0
16
18
5311
FHL
Bypass surgery in one vein
22.2
8.0
11
5
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.9
182
1159
I35
ICD-10 Finland
Nonrheumatic aortic valve disorders
13.1
7.9
13
10
L04AX01
ATC
azathioprine; systemic
2.8
7.9
50
186
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
7.9
40
130
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
3.5
7.8
34
98
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
7.8
175
1108
AC4
HP
MVP
10.9
7.8
14
13
R03AK08
ATC
formoterol and beclometasone; inhalant
3.4
7.8
36
109
4240X
ICD-9 Finland
Other diseases of endocardium, Mitral valve disorders[ALIUD VITIUM VALVULAE MITRALIS (NON RHEUMATICUM)]
45.3
7.7
9
*
40299
ICD-8 Finland
Hypertensive heart disease
5.6
7.7
21
38
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.0
7.7
41
138
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.7
341
2549
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.0
7.6
93
479
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
7.6
235
1615
5312
FHL
Bypass surgery for two vessels
11.9
7.6
13
11
R07.3
ICD-10 Finland
Other chest pain
1.9
7.4
100
537
I09.9
ICD-10 Finland
Rheumatic heart disease, unspecified
+∞
7.3
7
*
3900A
ICD-9 Finland
Rheumatic fever without mention of heart involvement[FEBRIS RHEUMATICA, MORBO CORDIS NON INDICATO]
+∞
7.3
7
*
C01BA03
ATC
disopyramide; systemic
5.0
7.3
22
45
L04AA06
ATC
mycophenolic acid; systemic
4.5
7.3
24
54
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
4.5
7.3
24
54
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.3
257
1822
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.5
7.2
53
216
N05CD07
ATC
temazepam; oral
1.6
7.2
176
1140
UJF32
NOMESCO Finland
Coloscopy
1.5
7.1
261
1862
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
7.1
215
1469
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
3.5
7.1
31
90
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
7.1
54
225
C01BA01
ATC
quinidine; oral
5.1
7.1
21
42
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
7.1
74
357
I40.9
ICD-10 Finland
Acute myocarditis, unspecified
8.8
7.1
14
16
N05CF01
ATC
zopiclone; oral
1.4
7.1
372
2865
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
10.1
7.0
13
13
R51.80
ICD-10 Finland
Headache
1.8
7.0
122
713
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.9
7.0
40
139
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
13.9
6.9
11
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
6.9
37
126
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.8
110
627
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
8.3
6.8
14
17
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
6.8
93
501
42100
ICD-8 Finland
Acute and subacute endocarditis, Acute and subacute bacterial endocarditis
40.3
6.8
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.7
331
2512
R03BA05
ATC
fluticasone; inhalant
1.6
6.7
175
1153
A02BC03
ATC
lansoprazole; oral
1.5
6.7
308
2305
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.2
6.7
62
286
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.6
254
1829
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.1
6.6
67
322
A46
ICD-10 Finland
Erysipelas
1.6
6.6
160
1033
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
4.4
6.5
22
51
P01BA02
ATC
hydroxychloroquine; oral
2.0
6.5
79
407
ZX120
NOMESCO Finland
Intravenous
1.9
6.5
99
556
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.6
6.5
43
166
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
70.2
6.4
7
*
5342
FHL
Reoperation due to leakage
70.2
6.4
7
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
6.4
86
460
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.8
6.4
38
138
2720X
ICD-9 Finland
Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]
14.4
6.4
10
7
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
6.4
108
625
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
3.8
6.4
25
67
N18.8
ICD-10 Finland
Other chronic renal failure
2.7
6.4
42
162
J01AA02
ATC
doxycycline; systemic
1.4
6.3
795
7072
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.3
133
827
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.3
425
3406
M01AH02
ATC
rofecoxib; oral
1.7
6.3
142
898
73
HP
Initial pacemaker installation
4.6
6.3
20
44
127
Kela drug reimbursment
Transplant complication
4.6
6.3
20
44
I97.0
ICD-10 Finland
Postcardiotomy syndrome
9.3
6.3
12
13
AB1
HP
AVR mechanical
9.3
6.3
12
13
I38
ICD-10 Finland
Endocarditis, valve unspecified
18.1
6.3
9
5
4412A
ICD-9 Finland
Aortic aneurysm, Thoracic aneurysm without mention of rupture
18.1
6.3
9
5
74659
ICD-8 Finland
Congenital anomalies of heart, Maleformatio valvulae mitralis
+∞
6.3
6
*
39899
ICD-8 Finland
Other heart disease, specified as rheumatic
+∞
6.3
6
*
I02.9
ICD-10 Finland
Rheumatic chorea without heart involvement
+∞
6.3
6
*
26
HP
Aortic root """"composite graft""""
+∞
6.3
6
*
39609
ICD-8 Finland
Diseases of mitral and aortic valves, Unspecified
+∞
6.3
6
*
I02.0
ICD-10 Finland
Rheumatic chorea with heart involvement
+∞
6.3
6
*
D59.4
ICD-10 Finland
Other nonautoimmune haemolytic anaemias
+∞
6.3
6
*
I09.0
ICD-10 Finland
Rheumatic myocarditis
+∞
6.3
6
*
39602
ICD-8 Finland
Diseases of mitral and aortic valves, Aortae operata
+∞
6.3
6
*
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.3
235
1686
H02AB07
ATC
prednisone; oral
1.6
6.2
164
1081
I49.5
ICD-10 Finland
Sick sinus syndrome
2.2
6.2
61
287
42400
ICD-8 Finland
Chronic disease of endocardium, Mitralis, non-operata
26.8
6.2
8
*
4210A
ICD-9 Finland
Acute and subacute endocarditis, Acute and subacute bacterial endocarditis
26.8
6.2
8
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
6.1
258
1896
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.7
6.1
111
663
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
4.4
6.1
20
46
L04AD01
ATC
ciclosporin; systemic
4.2
6.0
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022217) INR in Platelet poor plasma by Coagulation assay
283
1472
2.18
27.00
66.4
28.2
inr
2.1
1.4
3.40
25
181
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
467
3187
1.73
18.58
4.9
3.2
ng/l
2532.9
1968.5
1.35
427
2737
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
92
358
2.69
16.47
4.9
2.5
u/ml
0.3
0.4
0.76
62
203
(3022948) Iron [Moles/volume] in Serum or Plasma
254
1541
1.81
14.69
4.0
2.4
umol/l
11.5
12.3
1.17
233
1412
(3032080) INR in Blood by Coagulation assay
547
4090
1.59
14.19
31.4
10.6
inr
1.8
1.3
9.92
148
1142
(3020779) Urea [Moles/volume] in Serum or Plasma
159
858
1.97
13.13
12.1
6.7
mmol/l
12.6
11.3
1.19
147
813
(3004789) Transferrin [Mass/volume] in Serum or Plasma
230
1406
1.78
12.83
4.2
2.4
g/l
2.3
2.3
0.70
214
1294
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
43
125
3.52
12.71
5.7
5.8
mg/l
10.9
12.4
1.30
38
113
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
218
1331
1.77
12.17
4.4
2.4
%
20.7
21.9
0.65
193
1133
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
101
482
2.19
11.56
2.4
1.9
g/l
1.4
1.5
0.86
70
418
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
186
1107
1.80
11.28
4.5
3.9
u/l
289.2
255.2
1.37
178
1040
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
164
944
1.85
11.08
3.4
3.1
ng/l
294.9
249.2
0.56
150
857
(3000991) Gas panel - Venous blood
142
815
1.84
9.66
11.8
7.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
157
939
1.77
9.31
2.4
2.5
ug/l
11.7
6.4
1.03
138
796
(3007853) Bacteria identified in Skin by Aerobe culture
176
1099
1.70
8.94
2.7
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
390
2963
1.45
8.25
8.2
5.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
194
1269
1.62
8.21
10.0
5.2
mmol/l
1.1
1.0
1.09
176
1153
(3023368) Bacteria identified in Blood by Culture
379
2882
1.45
7.93
5.9
4.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
179
1161
1.63
7.83
9.4
6.7
mmol/l
1.1
1.3
0.19
133
882
(3019069) Monocytes/100 leukocytes in Blood
508
4089
1.40
7.67
9.1
5.7
%
9.0
8.8
0.77
474
3805
(3013115) Eosinophils [#/volume] in Blood
549
4478
1.40
7.67
9.1
5.5
e9/l
0.2
0.2
0.59
481
3907
(3006315) Basophils [#/volume] in Blood
532
4331
1.39
7.45
8.8
5.2
e9/l
0.0
0.0
0.20
468
3713
(3022096) Basophils/100 leukocytes in Blood
493
3964
1.40
7.43
8.8
5.5
%
0.6
0.6
0.04
458
3672
(3001604) Monocytes [#/volume] in Blood
529
4308
1.39
7.37
8.8
5.2
e9/l
0.6
0.6
1.76
463
3686
(3027456) Digoxin [Moles/volume] in Serum or Plasma
63
299
2.16
7.37
2.3
3.2
nmol/l
0.9
0.9
0.18
46
238
(3006504) Eosinophils/100 leukocytes in Blood
504
4073
1.39
7.35
8.7
5.5
%
2.8
2.9
0.58
468
3771
(3002030) Lymphocytes/100 leukocytes in Blood
515
4189
1.38
7.18
8.9
5.6
%
24.7
26.4
2.46
476
3878
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
176
1166
1.59
7.03
9.4
6.6
kpa
5.2
5.1
0.78
163
1099
(3027801) Oxygen [Partial pressure] in Arterial blood
176
1167
1.59
7.01
9.3
6.6
kpa
11.8
11.8
0.00
163
1103
(3014111) Lactate [Moles/volume] in Serum or Plasma
138
867
1.66
6.83
10.4
6.6
mmol/l
1.3
1.4
0.59
130
828
(3019198) Lymphocytes [#/volume] in Blood
537
4433
1.36
6.69
8.8
5.4
e9/l
1.8
1.9
0.54
471
3872
(3018010) Neutrophils/100 leukocytes in Blood
504
4121
1.37
6.66
8.5
5.5
%
60.2
58.4
2.63
469
3836
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
52
239
2.23
6.61
2.4
2.7
g/l
3.8
3.6
0.33
52
226
(3042733) HLA Ab [Presence] in Serum
11
18
6.16
6.43
5.2
4.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
157
1043
1.58
6.19
9.8
6.9
%
95.2
95.2
0.01
151
999
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
151
2.49
6.15
7.2
6.2
iu/ml
264.0
346.9
—
9
23
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
18
48
3.79
6.10
2.9
1.9
e6/l
374.5
623.8
0.69
13
41
(3023520) Reticulocytes [#/volume] in Blood
135
872
1.61
5.99
3.4
2.5
e9/l
69.7
69.4
0.04
106
673
(3011412) CD3 cells [#/volume] in Blood
21
64
3.32
5.87
2.8
1.8
e9/l
1.0
0.9
0.21
12
34
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
91
532
1.76
5.86
12.7
9.1
mmol/l
24.4
24.5
0.10
78
489
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
117
734
1.65
5.83
1.9
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
45
3.82
5.82
1.6
1.7
%
13.5
16.1
0.34
12
20
(3027945) Reticulocytes/100 erythrocytes in Blood
173
1194
1.52
5.75
3.5
2.4
%
1.8
1.8
0.16
156
1054
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
41
3.94
5.72
1.6
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
235
1729
1.44
5.66
2.0
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
177
1234
1.50
5.60
9.0
6.4
mmol/l
104.9
104.3
0.92
169
1199
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
271
2.04
5.53
2.2
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
31
123
2.56
5.48
3.0
2.6
—
657.5
—
0
11
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
51
252
2.07
5.45
1.6
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
85
501
1.75
5.34
2.2
1.6
g/l
1.4
1.4
0.02
80
459
(3024891) Influenza virus A+B Ag [Presence] in Specimen
50
248
2.06
5.30
1.1
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
8
11.32
5.29
2.0
4.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
173
1216
1.49
5.26
1.7
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
244
2.05
5.15
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
244
2.05
5.15
1.2
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
98
609
1.66
5.09
4.0
4.0
mmol/l
1.8
2.0
0.25
69
446
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
159
2.30
5.08
2.1
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
19
5.30
5.04
1.5
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
11
23
4.82
5.02
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
172
1224
1.47
4.91
1.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
461
3849
1.31
4.90
5.9
4.0
ng/l
58.7
58.9
0.01
356
2839
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
328
2609
1.35
4.90
3.0
2.2
mg/l
3.5
3.1
1.95
294
2191
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
68
386
1.80
4.87
4.3
4.6
mmol/l
25.2
25.0
0.40
59
359
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
81
484
1.72
4.87
5.5
3.5
mmol/l
24.0
24.1
0.15
69
439
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
90
554
1.67
4.85
11.3
7.6
mmol/l
24.9
24.9
0.00
90
549
(3000963) Hemoglobin [Mass/volume] in Blood
890
9610
0.76
4.80
39.4
23.5
g/l
130.3
133.1
5.66
871
9393
(3010813) Leukocytes [#/volume] in Blood
890
9610
0.76
4.80
39.1
23.4
e9/l
7.0
6.9
0.57
860
9262
(3026361) Erythrocytes [#/volume] in Blood
890
9607
0.76
4.76
39.1
23.4
e12/l
4.4
4.4
1.73
861
9263
(3035941) MCH [Entitic mass]
890
9606
0.76
4.75
38.9
23.3
pg
30.1
30.4
3.22
872
9388
(3007461) Platelets [#/volume] in Blood
890
9605
0.76
4.74
39.1
23.4
e9/l
231.5
242.4
4.72
862
9295
(3024731) MCV [Entitic volume]
890
9605
0.76
4.74
38.9
23.3
fl
91.1
91.4
0.92
872
9390
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
97
613
1.63
4.73
12.3
8.4
%
0.6
0.7
0.73
97
607
(3009343) pH of Capillary blood
100
637
1.62
4.72
4.1
4.0
ph
7.4
7.4
—
9
75
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
101
647
1.61
4.67
4.1
4.0
kpa
5.2
5.2
0.03
92
598
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
506
4299
1.29
4.66
9.7
5.7
mmol/l
1.2
1.2
2.60
459
3838
(3026493) Urate [Moles/volume] in Serum or Plasma
294
2331
1.34
4.44
4.0
2.7
umol/l
3730.7
8837.9
1.53
246
1958
(3012095) Magnesium [Moles/volume] in Serum or Plasma
200
1491
1.40
4.44
4.8
3.1
mmol/l
0.8
0.8
0.70
187
1375
(3013650) Neutrophils [#/volume] in Blood by Automated count
582
5068
1.27
4.31
11.4
8.3
e9/l
4.4
4.3
0.56
507
4404
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
96
620
1.59
4.30
12.3
8.3
%
1.3
1.4
0.27
96
614
(3024932) HLA-DR beta [Type]
10
22
4.57
4.30
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
119
812
1.51
4.19
1.9
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
103
685
1.55
4.08
3.1
2.9
ml/min/173m2
62.1
61.3
0.07
55
293
(3021788) Differential panel - Synovial fluid
34
162
2.13
4.06
1.9
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
31
143
2.20
4.01
1.6
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
137
2.22
3.98
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
226
1.93
3.95
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
134
955
1.45
3.82
6.4
3.4
mmol/l
1.5
2.0
1.10
113
738
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
277
2223
1.31
3.80
3.2
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
92
607
1.56
3.79
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
109
748
1.50
3.75
5.6
3.6
ng/l
135.4
91.5
1.72
96
642
(3042936) Bacteria identified in Isolate by Culture
184
1392
1.38
3.74
3.1
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
445
3801
1.26
3.73
4.3
2.7
ug/l
167.6
140.8
0.59
416
3431
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
539
4717
1.25
3.63
10.3
6.5
mmol/l
1.2
1.2
1.75
456
3924
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
255
1.83
3.63
2.2
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
213
1.91
3.57
2.1
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
80
519
1.58
3.56
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
185
1.97
3.55
2.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
72
456
1.61
3.54
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
274
2216
1.30
3.53
9.4
6.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
133
961
1.43
3.53
6.5
3.4
kpa
5.9
5.8
0.39
127
928
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
223
1.87
3.44
2.1
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
212
2655
0.76
3.34
2.8
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
546
4818
1.23
3.32
7.1
6.0
umol/l
13.4
12.1
1.19
514
4543
(3024354) Oxygen [Partial pressure] in Venous blood
113
802
1.45
3.31
6.1
2.8
kpa
4.4
4.5
0.09
107
773
(3009542) Hematocrit [Volume Fraction] of Blood
714
7785
0.81
3.31
30.0
17.5
%
38.6
38.9
0.50
483
5158
(3037522) Nuclear Ab [Titer] in Serum
140
1037
1.39
3.24
1.4
1.3
titre
608.8
428.7
0.55
32
227
(3022313) Gas panel - Capillary blood
72
467
1.57
3.23
4.4
4.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
16
60
2.69
3.23
5.3
3.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
42
237
1.80
3.16
6.6
3.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
78
519
1.54
3.14
14.3
9.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
39
3.10
3.09
3.2
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
39
3.10
3.09
1.7
3.8
%
95.8
98.4
0.11
12
39
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
39
3.10
3.09
3.2
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
338
2849
1.25
3.09
2.7
2.5
u/l
59.1
57.7
0.23
310
2612
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
330
1.66
3.09
5.6
3.5
mg/l
63.2
73.7
0.21
42
269
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
332
1.65
3.02
5.6
3.5
mg/l
41.4
48.3
0.27
42
273
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
12
5.86
3.02
1.1
1.1
%
93.1
89.8
—
7
12
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
12
5.86
3.02
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
40
226
1.79
3.01
1.7
1.7
e6/l
21537.3
15931.6
0.36
34
161
(3013826) Glucose [Moles/volume] in Serum or Plasma
611
5495
1.21
2.98
7.4
4.7
mmol/l
6.8
6.8
0.07
573
5146
(3044640) Blood type and Crossmatch panel - Blood
349
2963
1.24
2.98
3.4
2.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
40
3.02
2.97
3.2
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
115
2.11
2.89
1.8
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
195
1547
1.31
2.89
1.7
1.4
g/l
2.9
2.6
0.65
110
912
(3022806) Fractional oxyhemoglobin in Capillary blood
25
123
2.05
2.82
1.6
1.8
%
89.1
89.8
0.23
25
123
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
139
1057
1.35
2.76
2.5
2.8
umol/l
9.1
9.5
0.07
114
914
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
125
2.02
2.72
1.7
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
98
2.16
2.71
3.9
2.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
54
2.61
2.71
3.6
2.2
e6/l
597.6
768.5
—
5
24
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
866
9184
0.82
2.66
14.4
10.3
u/l
24.8
25.3
0.39
829
8765
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
236
1940
1.27
2.65
5.4
4.0
ng/l
539.1
338.4
0.32
207
1614
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
202
1629
1.29
2.65
3.6
2.9
e6/l
1.3
1.1
0.19
113
953
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
337
1.60
2.63
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
778
8331
0.83
2.63
5.1
4.7
mmol/l
6.1
6.0
0.46
705
7400
(3033658) Prothrombin time (PT) actual/Normal
278
2331
1.25
2.63
5.2
3.9
%
73.2
85.8
8.24
271
2275
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
15
4.69
2.60
7.6
8.1
—
—
—
0
0
(4024509)
17
74
2.31
2.58
1.7
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
38
2.91
2.58
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
38
2.91
2.58
1.9
2.2
u/ml
606.4
835.2
0.60
11
38
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
107
2.07
2.58
3.8
3.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
128
1.97
2.56
1.6
1.2
u/ml
221.5
292.8
0.72
19
74
(3019060) Gas panel - Arterial blood
95
688
1.41
2.54
4.8
3.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
114
852
1.37
2.54
3.6
2.7
g/l
65.4
66.1
0.43
106
759
(3003338) MCHC [Mass/volume]
663
7189
0.84
2.53
36.2
21.0
g/l
329.7
331.7
5.94
653
7105
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
143
1.91
2.52
2.0
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
403
3526
1.21
2.52
4.6
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
75
2.28
2.51
1.3
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
308
2625
1.23
2.50
4.3
3.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
36
210
1.73
2.48
4.9
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
210
1.73
2.48
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
82
2.21
2.48
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
318
2722
1.22
2.47
4.3
3.3
e6/l
0.7
0.5
0.82
255
2110
(3000850) Epithelial cells [#/volume] in Urine
255
2134
1.24
2.45
3.3
2.6
e6/l
6.2
5.4
0.41
227
1884
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
126
963
1.34
2.44
1.9
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
83
2.19
2.41
3.3
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
798
8498
0.84
2.41
5.3
5.0
mmol/l
2.5
2.6
3.55
733
7634
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
6
12
5.02
2.40
1.3
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
655
1.40
2.36
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
47
299
1.59
2.36
5.3
3.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
64
438
1.49
2.32
3.3
3.1
pmol/l
4.2
4.5
1.84
59
381
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
126
1.92
2.31
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
65
447
1.48
2.31
1.3
1.2
u/ml
104.8
223.4
1.28
56
404
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
35
2.87
2.30
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
35
2.87
2.30
1.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
203
0.39
2.29
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
852
9006
0.84
2.29
25.2
15.4
—
—
—
0
0
(3026782) Osmolality of Urine
243
2038
1.24
2.29
3.7
2.9
mosm/kgh2o
531.1
552.6
0.97
207
1735
(3002179) Metamyelocytes/100 leukocytes in Blood
89
651
1.39
2.28
5.7
3.8
%
0.8
0.6
0.52
22
160
(3048689) Calprotectin [Mass/mass] in Stool
119
912
1.34
2.28
2.4
2.1
ug/g
129.5
134.9
0.08
98
721
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
227
2697
0.81
2.25
4.6
4.5
%
21.8
21.7
0.04
116
1376
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
155
1922
0.78
2.23
3.0
3.1
ug/l
0.8
0.8
0.20
110
1325
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
135
1.87
2.23
1.5
1.3
e6/l
13008.3
88021.7
0.94
16
77
(3037121) Protein [Mass/volume] in Urine
51
336
1.54
2.22
3.7
3.2
g/l
0.2
0.3
0.21
28
136
(3012441) Differential panel - Pleural fluid
24
128
1.89
2.22
1.5
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
30
172
1.76
2.22
1.5
1.5
g/l
29.6
30.7
0.24
23
155
(3023103) Potassium [Moles/volume] in Serum or Plasma
864
9111
0.84
2.20
32.2
19.3
mmol/l
4.0
4.0
1.40
840
8800
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
54
2.42
2.20
1.9
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
54
2.42
2.20
17.0
17.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
54
2.42
2.20
2.4
2.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
42
2.63
2.19
2.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
42
2.63
2.19
2.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
136
1.85
2.18
1.5
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
39
242
1.63
2.18
1.7
1.6
iu/ml
0.0
22.9
—
9
53
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
289
3341
0.83
2.18
4.6
5.2
ug/l
2.7
4.7
0.83
258
2943
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
14
4.30
2.15
2.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
14
4.30
2.15
5.5
8.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
863
9091
0.84
2.12
31.9
19.2
mmol/l
139.3
139.6
1.57
840
8793
(4062490)
15
68
2.22
2.11
1.9
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
244
2066
1.22
2.10
4.4
3.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
124
1.87
2.08
2.0
1.4
u/ml
104.4
115.2
—
5
24
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
31
2.92
2.07
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
773
8209
0.85
2.07
4.7
4.4
mmol/l
1.4
1.4
3.39
707
7365
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
110
847
1.33
2.06
2.4
2.3
u/l
36.9
34.3
0.22
90
715
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
103
1.96
2.06
1.3
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
96
725
1.35
2.04
6.0
3.9
%
1.0
0.9
0.23
31
223
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
781
8284
0.85
2.04
4.7
4.4
mmol/l
4.3
4.5
4.33
718
7489
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
325
2837
1.20
2.03
4.0
4.0
mg/mmol
18.2
9.2
1.55
218
1821
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
744
7920
0.86
2.03
4.3
3.9
mmol/l
1.3
1.3
0.62
682
7049
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
83
2.06
2.01
3.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
83
2.06
2.01
3.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
83
2.06
2.01
3.2
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
38
2.64
2.01
1.1
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
754
8010
0.86
1.97
6.6
6.1
mmol/mol
41.1
40.7
0.43
697
7284
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
21
3.35
1.96
1.9
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
105
1.92
1.96
5.4
3.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
134
1.81
1.96
1.8
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
27
2.97
1.93
2.0
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
120
1.85
1.93
2.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
33
2.74
1.93
4.6
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
33
2.74
1.93
4.6
3.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
92
1.97
1.90
3.3
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.32
1.88
3.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.32
1.88
3.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.32
1.88
3.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.32
1.88
3.2
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
17
3.54
1.84
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
262
1.54
1.83
1.5
1.5
ug/g
287.8
276.3
0.15
26
153
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
12
4.18
1.82
21.0
11.1
mmol/l
3.9
6.6
—
5
12
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
324
2854
1.18
1.82
2.8
2.1
u/l
170.7
248.7
1.56
312
2661
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
51
354
1.46
1.78
3.3
2.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
89
681
1.33
1.77
6.3
4.0
%
0.2
0.1
0.11
26
206
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
67
2.10
1.76
1.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
338
3001
1.17
1.72
4.4
3.4
e6/l
136.3
96.9
0.19
267
2364
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
185
1556
1.22
1.71
3.8
3.1
e6/l
2.6
2.2
0.28
95
888
(3047189) Immunofixation for 24 hour Urine
11
48
2.30
1.70
2.9
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
548
0.67
1.67
1.3
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
97
1.87
1.66
1.9
1.6
%
60.2
64.0
0.16
13
71
(3033799) Differential panel - Peritoneal fluid
7
25
2.81
1.65
1.9
2.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
314
2780
1.17
1.65
3.6
3.1
mmol/l
7.0
7.4
0.78
258
2275
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
76
1.99
1.64
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
90
699
1.31
1.63
3.3
2.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
158
1.66
1.63
2.0
2.2
u/l
417.1
3048.1
—
8
58
(3018095) Leukocytes [#/volume] in Urine
380
3420
1.16
1.61
5.1
3.9
e6/l
156.6
138.0
0.12
286
2520
(3023199) Leukocytes [#/volume] in Pleural fluid
25
151
1.67
1.60
1.6
1.4
e6/l
1453.0
1320.3
0.09
16
104
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
63
2.07
1.60
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1726
1.20
1.60
1.3
1.2
u/ml
1.0
1.5
0.61
45
438
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
152
1.66
1.57
1.9
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
40
273
1.48
1.55
1.3
1.2
u/ml
0.3
1.4
—
5
23
(3019309) Folate [Moles/volume] in Red Blood Cells
242
2111
1.18
1.52
1.9
1.8
nmol/l
1328.3
1191.2
1.21
187
1549
(3039443) Prostate specific Ag panel - Serum or Plasma
6
144
0.41
1.51
2.5
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
72
1.95
1.49
2.1
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
65
2.01
1.49
1.4
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
318
2841
1.16
1.48
6.9
3.8
ph
7.4
7.4
0.48
50
541
(3043409) Potassium [Moles/volume] in Arterial blood
44
310
1.43
1.47
3.5
3.2
mmol/l
3.8
3.9
2.17
38
284
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
148
1238
1.22
1.46
1.3
1.3
u/ml
9.5
11.4
0.18
43
450
(3037756) Immunofixation for Serum or Plasma
34
228
1.50
1.45
1.9
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
212
1.52
1.44
5.1
3.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
16
3.13
1.44
1.8
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
66
1.98
1.43
1.7
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
31
205
1.52
1.41
2.5
2.4
%
16.0
15.3
0.32
14
103
(3045424) Erythrocytes [Presence] in Urine
21
126
1.68
1.40
1.8
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
46
2.18
1.40
1.6
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
41
2.20
1.37
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
23
2.62
1.37
1.3
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
285
0.59
1.36
1.2
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
167
1.57
1.35
4.9
3.4
%
56.0
59.9
0.91
26
167
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
369
0.64
1.34
1.2
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
107
874
1.24
1.34
2.5
2.1
g/l
0.2
0.2
0.01
98
798
(40760892) CBC W Ordered Manual Differential panel - Blood
208
1813
1.18
1.33
6.7
4.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
421
3862
1.13
1.33
14.5
9.5
e9/l
0.0
0.0
0.30
338
3124
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
121
1.66
1.31
1.5
1.4
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
24
2.51
1.30
1.3
1.5
g/l
16.8
14.5
—
6
17
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
161
1.56
1.29
3.0
3.1
e9/l
3.8
4.4
1.14
25
161
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
18
2.78
1.28
1.4
1.5
—
—
—
0
0
(4198724)
5
18
2.78
1.28
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
122
1.65
1.27
1.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
154
1.57
1.26
5.3
2.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
123
1.64
1.24
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
123
1.64
1.24
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
123
1.64
1.24
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
152
1298
1.19
1.24
1.3
1.3
iu/ml
38.4
35.6
0.11
42
399
(3026008) Bacteria identified in Urine by Culture
346
3147
1.14
1.24
3.8
3.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
61
469
1.32
1.24
8.4
3.7
%
51.2
47.3
0.62
61
463
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
373
1.35
1.24
1.5
2.5
g/l
10.3
10.5
0.13
43
313
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
155
1.56
1.23
7.4
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
67
850
0.78
1.23
1.9
1.7
%
1.6
1.5
0.57
60
725
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
227
0.57
1.22
1.3
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
80
639
1.27
1.22
6.5
4.0
%
0.2
0.6
0.33
22
171
(40761535) Cells panel - Urine sediment
100
820
1.24
1.22
4.3
3.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
19
2.64
1.21
1.0
1.4
—
—
—
0
0
(44806420)
8
37
2.17
1.21
2.0
2.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
37
2.17
1.21
2.6
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
124
1.62
1.21
1.5
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
44
323
1.38
1.21
1.6
2.5
g/l
36.9
37.2
0.12
39
272
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
205
1.47
1.20
1.5
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
101
1.69
1.20
1.2
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
18
109
1.66
1.19
1.3
1.2
nmol/l
—
0.7
—
0
6
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
402
1.33
1.19
1.5
2.4
g/l
7.2
7.5
0.48
41
298
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
149
1.55
1.17
4.1
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
377
1.34
1.17
1.5
2.5
g/l
3.3
3.2
0.20
42
292
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
57
1.94
1.17
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
193
2192
0.86
1.17
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
50
2.01
1.16
1.8
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
72
1.81
1.15
4.5
1.5
%
10.1
10.9
0.32
13
72
(40768806) Pleura Pathology biopsy report
22
142
1.56
1.14
1.6
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
677
7109
0.90
1.13
32.8
19.5
%
14.3
13.9
6.95
661
6933
(3049717) Cytology report of Urine Cyto stain
55
423
1.31
1.13
2.6
2.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
295
2671
1.14
1.13
3.5
3.2
mg/l
307.6
297.5
0.01
200
1724
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
111
1.63
1.12
4.2
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
58
1.90
1.12
2.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
58
1.90
1.12
2.2
1.3
—
—
—
0
0
(3020891) Body temperature
52
398
1.32
1.11
4.5
3.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
73
1.79
1.11
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
96
1.68
1.10
1.1
1.1
u/ml
0.8
1.1
—
6
35
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
32
2.19
1.08
1.7
1.4
—
—
—
0
0
(4010399)
74
597
1.25
1.07
1.2
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
401
1.31
1.06
1.5
2.4
g/l
4.0
3.7
0.69
41
287
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
402
1.31
1.05
1.5
2.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
46
1.96
1.03
1.7
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
122
1.57
1.03
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
849
8781
0.90
0.99
27.5
16.2
mg/l
23.6
26.5
2.04
744
7123
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
448
4186
1.11
0.99
5.2
4.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
63
504
1.26
0.99
6.9
3.2
mmol/l
24.5
25.1
0.80
63
488
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
125
1074
1.18
0.98
4.8
4.6
%
31.4
32.5
0.57
97
678
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
49
1.84
0.98
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
37
275
1.36
0.98
1.3
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
31
0.00
0.96
0.0
1.5
—
7.0
—
0
17
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
417
1.28
0.96
2.4
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
758
7875
0.91
0.95
5.1
4.6
mu/l
2.0
2.1
0.30
687
7045
(3004451) EKG impression Narrative
9
51
1.77
0.94
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
277
1.35
0.94
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
210
1.39
0.91
1.5
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
102
1.58
0.90
1.7
2.2
u/field
3.9
2.1
—
7
28
(3017446) Testosterone [Moles/volume] in Serum or Plasma
49
616
0.79
0.89
2.0
2.2
nmol/l
13.6
12.8
0.27
44
533
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
103
1.56
0.87
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
95
1.59
0.87
1.1
1.2
nmol/l
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
281
1.33
0.87
1.3
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
44
1.82
0.86
2.1
2.6
u/l
271.3
215.8
—
8
44
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
619
6472
0.92
0.85
4.2
3.8
pmol/l
15.0
14.9
0.45
560
5751
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
301
2776
1.11
0.85
3.6
3.1
u/l
34.5
35.0
0.05
283
2630
(3021387) Prolactin [Units/volume] in Serum or Plasma
13
203
0.64
0.84
1.8
1.6
mu/l
379.3
298.3
0.33
13
185
(3024561) Albumin [Mass/volume] in Serum or Plasma
444
4177
1.10
0.84
6.2
4.6
g/l
34.3
34.8
1.05
400
3834
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
533
0.78
0.83
1.4
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
121
1.49
0.83
3.3
2.8
—
—
—
0
0
(4035726)
60
730
0.81
0.83
1.6
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
723
6956
1.09
0.82
9.7
7.2
u/l
83.3
80.4
0.70
678
6445
(3044242) Glucose [Moles/volume] in Arterial blood
11
65
1.70
0.82
1.2
2.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
81
1.61
0.81
1.1
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
30
224
1.35
0.80
6.3
4.3
kpa
8.5
8.4
0.03
30
219
(36660697) Celiac disease serology panel - Serum
70
585
1.21
0.78
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
234
1.33
0.78
1.6
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
132
1165
1.15
0.77
1.7
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
778
8034
0.92
0.77
23.7
15.3
ml/min/173m2
72.9
75.4
1.85
661
6638
(3014051) Protein [Presence] in Urine by Test strip
14
209
0.67
0.76
1.9
2.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
75
1.61
0.75
2.1
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
263
2428
1.10
0.74
5.3
4.2
estimate
0.0
0.0
0.69
80
783
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
379
1.25
0.74
1.8
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
150
1.41
0.73
2.0
2.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
25
2.00
0.72
1.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
25
2.00
0.72
6.4
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
522
0.80
0.72
5.6
4.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
40
1.75
0.71
2.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
9
57
1.58
0.71
2.7
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
57
1.58
0.71
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
57
1.58
0.71
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
57
1.58
0.71
1.3
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
2.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
58
1.56
0.70
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
58
1.56
0.70
1.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
58
1.56
0.70
2.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
58
1.56
0.70
2.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
58
1.56
0.70
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
85
1.53
0.69
6.2
2.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
35
275
1.28
0.68
3.5
3.1
mmol/l
23.3
24.7
1.10
30
235
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
175
1924
0.90
0.68
2.6
3.1
mmol/l
2.5
2.5
0.15
134
1659
(3032057) Clostridioides difficile [Presence] in Stool
5
27
1.86
0.68
1.4
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
119
0.59
0.68
1.4
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
37
294
1.27
0.67
1.4
1.6
—
198.8
—
0
17
(3012501) Base excess in Blood by calculation
29
223
1.31
0.66
6.3
4.3
mmol/l
2.7
2.7
0.00
24
149
(3000764) Benzodiazepines [Presence] in Urine
26
197
1.33
0.66
3.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
197
1.33
0.66
3.9
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
45
367
1.23
0.66
1.1
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
29
224
1.30
0.65
6.3
4.3
kpa
5.1
5.1
0.02
29
219
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
216
1.30
0.63
2.3
2.2
g/l
124.8
125.4
0.04
20
160
(3047181) Lactate [Moles/volume] in Blood
37
297
1.25
0.62
7.9
5.6
mmol/l
1.2
1.3
0.41
32
258
(3028300) Cannabinoids [Presence] in Urine
26
199
1.31
0.62
3.9
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
71
1.55
0.62
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
49
1.64
0.62
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
173
1.34
0.62
1.7
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
30
1.67
0.61
1.8
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
88
1.48
0.60
1.1
1.1
u/ml
0.5
0.6
—
6
32
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
672
6500
1.07
0.60
5.7
4.0
mm/h
15.4
14.0
1.42
618
5896
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
97
1.45
0.59
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
97
1.45
0.59
1.4
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
196
0.71
0.57
2.1
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
70
806
0.86
0.57
9.2
3.7
mmol/l
1.2
1.2
0.60
63
687
(40768804) Tissue Pathology biopsy report
322
3409
0.93
0.57
2.1
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
113
1012
1.13
0.57
1.8
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
54
1.48
0.57
1.8
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
6
36
1.67
0.56
1.0
1.3
mmol/l
4.8
3.6
—
6
30
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
87
0.57
0.56
1.2
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
55
1.46
0.56
1.8
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
45
376
1.20
0.55
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
29
231
1.26
0.54
2.9
2.4
ug/min
184.8
91.5
0.56
18
140
(46235355) HIV 1 and 2 tests - Meaningful Use set
127
1155
1.11
0.51
2.1
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
109
1.38
0.51
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
538
1.16
0.50
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
298
1.21
0.49
1.7
1.9
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
45
1.56
0.49
1.3
1.3
mmol/l
2.0
1.9
—
7
45
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
109
0.64
0.48
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
93
1.40
0.48
1.1
1.0
u/ml
3.5
8.0
—
6
42
(3035880) pH of Pleural fluid
11
76
1.45
0.48
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
199
1.26
0.48
3.8
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
456
4382
1.06
0.48
6.5
5.4
estimate
0.0
0.0
0.00
87
826
(3035350) Ketones [Presence] in Urine by Test strip
456
4383
1.06
0.47
4.9
3.9
estimate
0.0
0.0
0.00
84
834
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
473
0.84
0.47
1.2
1.2
iu/ml
46.8
143.4
2.09
15
187
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
392
1.18
0.47
1.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
646
6275
1.06
0.47
6.1
4.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
12
165
0.72
0.46
1.3
1.2
mmol/l
4.3
3.8
0.55
12
153
(3002256) Pathology report gross observation
101
1115
0.90
0.46
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
24
192
1.25
0.45
3.0
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
522
5394
0.95
0.44
3.5
3.1
u/l
64.4
52.1
1.51
476
4938
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
459
4759
0.94
0.44
2.8
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
95
1.37
0.43
1.5
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
184
1.25
0.43
4.1
1.7
—
—
—
0
0
(3000492) Spirometry study
84
755
1.12
0.43
1.5
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3013512) EKG study
294
2797
1.07
0.42
5.8
4.1
—
—
—
0
0
(3019225) pH of Specimen
100
909
1.11
0.42
5.0
4.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
58
510
1.14
0.42
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
63
558
1.14
0.41
4.4
3.1
e9/l
4.2
4.2
0.02
49
420
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
13
172
0.75
0.41
2.3
1.3
e6/l
461.8
801.6
0.21
13
141
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
13
172
0.75
0.41
2.2
1.2
e6/l
4.6
27.1
0.66
13
137
(3008037) Lactate [Moles/volume] in Venous blood
30
250
1.20
0.40
7.9
3.3
mmol/l
1.5
1.6
0.43
30
245
(3028433) Virus identified in Specimen by Culture
5
34
1.47
0.40
1.6
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.0
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
87
788
1.11
0.40
1.7
1.9
nmol/l
345.4
373.0
0.82
79
716
(3031040) Bacteria [#/volume] in Urine by Automated count
637
6207
1.05
0.40
6.2
5.0
e6/l
187.8
2690.3
1.96
11
107
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
223
1.22
0.40
4.1
4.0
mg/l
20.3
28.3
0.98
20
159
(4306422)
7
103
0.68
0.39
1.1
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
61
1.31
0.39
1.1
1.2
—
70.4
—
0
7
(3003327) Ova and parasites identified in Stool by Light microscopy
28
233
1.21
0.38
1.7
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
91
997
0.91
0.38
3.3
4.1
ug/l
7.4
27.9
1.49
76
843
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
69
1.31
0.37
2.8
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
37
1.35
0.37
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
554
1.13
0.37
1.9
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
609
6241
0.95
0.36
5.6
4.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
54
607
0.88
0.36
3.0
3.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
77
0.65
0.35
1.2
1.1
—
—
—
0
0
(44806118)
13
99
1.32
0.35
2.0
1.5
—
—
—
0
0
(44790049)
13
99
1.32
0.35
2.0
1.5
—
—
—
0
0
(44790048)
13
99
1.32
0.35
2.0
1.5
—
—
—
0
0
(44790047)
13
99
1.32
0.35
2.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
458
4438
1.05
0.35
4.9
4.0
estimate
0.0
0.0
0.50
85
814
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
136
1.25
0.33
1.6
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
118
1.27
0.33
3.0
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
201
1907
1.06
0.33
2.0
1.7
mg/l
1.0
1.3
1.44
148
1490
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
46
1.31
0.33
3.3
4.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
617
1.11
0.32
1.9
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
165
0.79
0.32
1.5
1.4
—
—
—
0
0
(44813793)
7
52
1.35
0.31
1.1
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
98
0.71
0.31
1.3
1.2
%
105.4
115.8
—
7
91
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
53
1.32
0.31
2.1
3.1
—
—
—
0
0
(4094501)
25
212
1.18
0.30
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
33
378
0.87
0.30
1.9
3.2
u/ml
31.5
10625.4
0.84
25
325
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
227
2176
1.05
0.28
1.6
1.6
mmol/l
1.3
1.3
0.30
197
1810
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
16
194
0.82
0.27
4.9
3.9
u/ml
41.1
1515.8
0.62
16
183
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
120
0.75
0.27
1.4
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
204
0.83
0.27
1.6
1.8
nmol/l
45.7
39.8
0.29
17
192
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
159
1.20
0.27
1.8
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
187
1.18
0.26
1.5
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
67
1.20
0.26
1.6
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
171
0.82
0.26
1.4
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
72
0.69
0.26
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
789
0.92
0.26
5.7
4.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
206
1976
1.05
0.25
5.5
4.4
kg/l
1.0
1.0
0.61
31
286
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
255
0.86
0.24
1.6
1.7
mg/l
6.3
3.2
0.43
14
192
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
148
0.81
0.24
1.7
2.1
pmol/l
285.0
218.8
0.66
12
139
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
126
0.79
0.24
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
87
928
0.93
0.23
1.3
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
38
1.32
0.23
4.0
6.1
—
87.6
—
0
9
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
97
1.24
0.23
1.4
1.2
—
60.7
—
0
8
(3004616) Nuclear Ab [Presence] in Serum
11
88
1.25
0.22
1.4
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
351
3418
1.04
0.22
5.2
4.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
146
0.82
0.22
1.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
116
1.21
0.22
1.0
1.1
—
—
—
0
0
(4211845)
5
42
1.19
0.21
1.2
3.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
12
0.00
0.21
0.0
1.3
—
18.1
—
0
7
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
218.0
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
120
1143
1.06
0.20
12.3
8.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
108
1.21
0.20
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
336
1.10
0.20
1.8
2.0
u/l
39.3
39.3
0.01
31
293
(3003181) Sodium [Moles/volume] in Urine
20
174
1.15
0.19
1.3
1.3
mmol/l
56.6
61.9
0.21
14
139
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
186
0.86
0.19
1.3
1.2
mg/l
376.1
475.9
0.68
16
175
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
174
0.86
0.18
1.3
1.3
miu/ml
222.8
238.5
—
7
80
(4281824)
10
82
1.22
0.17
1.6
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
68
0.73
0.17
2.2
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
148
1.15
0.17
2.1
1.2
—
—
—
0
0
(4146454)
12
101
1.19
0.16
2.6
2.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
177
1.13
0.16
1.9
1.5
u/l
11.9
10.5
0.20
15
136
(3050129) First trimester maternal screen panel - Serum or Plasma
11
130
0.84
0.16
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
98
937
1.05
0.15
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
76
0.79
0.15
1.7
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
79
0.76
0.15
3.5
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
23
207
1.11
0.15
1.3
1.2
—
33.0
—
0
10
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
522
0.94
0.14
3.0
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
103
1.17
0.13
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
366
3598
1.02
0.13
2.8
2.2
nmol/l
80.1
77.8
0.85
332
3129
(4034850)
31
286
1.09
0.13
19.2
11.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
151
1.13
0.13
1.3
1.2
—
29.1
—
0
12
(3019832) Treponema pallidum Ab [Presence] in Serum
48
509
0.94
0.13
2.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
124
1.13
0.11
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
77
798
0.96
0.09
1.7
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
113
0.88
0.08
1.6
1.2
u/ml
9.0
5.7
—
5
52
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
65
0.77
0.08
1.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
70
0.86
0.07
1.2
1.3
—
56.3
—
0
8
(21494434) Karyotype in Bone marrow
11
98
1.12
0.07
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
74
0.81
0.07
1.5
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
74
0.81
0.07
1.2
1.4
—
322.0
—
0
10
(3032773) Endomysium IgG Ab [Titer] in Serum
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
78
1.03
0.07
1.4
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
83
0.84
0.07
1.9
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
245
1.06
0.07
2.4
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
85
0.82
0.07
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
107
1048
1.02
0.06
4.7
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
38
365
1.04
0.06
1.8
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
129
1.09
0.05
9.1
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
189
1.06
0.04
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
140
1.07
0.04
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
29
302
0.96
0.04
7.4
5.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
101
1.09
0.04
2.9
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
214
2125
1.01
0.02
1.8
1.7
pmol/l
50270714.3
9203247.0
0.38
185
1706
(3021960) Folate [Moles/volume] in Serum or Plasma
236
2372
0.99
0.02
1.8
1.6
nmol/l
21.2
20.4
0.27
206
1988
(40768797) Stomach Pathology biopsy report
119
1182
1.01
0.01
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
323
3239
1.00
0.01
3.0
3.2
mmol/l
2.3
2.3
0.21
269
2764
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
106
0.94
0.01
1.6
1.2
u/ml
3.4
4.3
—
5
35
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
124
0.97
0.00
2.3
2.3
u/ml
4.2
38.1
0.55
12
119
(3005570) Glucose [Moles/volume] in Urine
10
102
0.98
0.00
3.2
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
128
1.02
0.00
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
252
0.99
0.00
2.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
269
1.00
0.00
1.6
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
117
1.03
0.00
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
28
283
0.99
0.00
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
238
2375
1.00
0.00
4.5
3.7
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
2.3
nmol/l
24.8
18.4
—
5
47
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
12.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
399
3990
1.00
0.00
2.3
2.1
pmol/l
93.6
92.9
0.11
212
2035
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.0
—
2.3
—
0
5
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
8
82
0.98
0.00
1.3
1.5
—
22.2
—
0
15
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
250
1.00
0.00
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
63
0.95
0.00
2.3
2.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
55
0.91
0.00
2.4
2.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
465.6
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
75
0.93
0.00
3.0
2.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_RHEUFEV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_RHEUFEV | 2.108 [1.91, 2.33] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.153 |
During the follow-up period (1.1.1998 — 31.12.2019), 1814 out of 3349 females with I9_RHEUFEV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_RHEUFEV | 1.918 [1.69, 2.18] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1381 out of 2720 males with I9_RHEUFEV died.
Mortality risk
Mortality risk for people of age
years, who have I9_RHEUFEV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.123% | 0.234% |
| 5 | 0.939% | 1.818% |
| 10 | 2.767% | 4.92% |
| 15 | 5.439% | 8.981% |
| 20 | 9.551% | 15.703% |
Relationships between endpoints
↥Index endpoint: I9_RHEUFEV – Rheumatic fever incl heart disease
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data